PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,405,000 | -46.5% | 350,000 | -30.0% | 1.01% | -14.4% |
Q1 2022 | $38,160,000 | -62.8% | 500,000 | -70.7% | 1.18% | -62.9% |
Q4 2021 | $102,626,000 | +45.5% | 1,705,599 | +35.4% | 3.16% | +57.5% |
Q3 2021 | $70,533,000 | -8.7% | 1,259,518 | -1.1% | 2.01% | +8.8% |
Q2 2021 | $77,255,000 | -22.0% | 1,273,161 | -10.0% | 1.85% | -18.9% |
Q1 2021 | $99,097,000 | +17.1% | 1,413,854 | 0.0% | 2.28% | +3.6% |
Q4 2020 | $84,605,000 | +12.1% | 1,413,854 | +12.6% | 2.20% | -6.7% |
Q3 2020 | $75,487,000 | +11.5% | 1,255,608 | -2.7% | 2.35% | +8.8% |
Q2 2020 | $67,683,000 | +17.6% | 1,289,941 | -24.9% | 2.16% | -1.5% |
Q1 2020 | $57,562,000 | -26.0% | 1,716,727 | 0.0% | 2.20% | +30.8% |
Q4 2019 | $77,768,000 | +19.0% | 1,716,727 | 0.0% | 1.68% | +28.3% |
Q3 2019 | $65,356,000 | +56.7% | 1,716,727 | +79.0% | 1.31% | +84.6% |
Q2 2019 | $41,707,000 | +119.2% | 958,997 | +91.8% | 0.71% | +249.3% |
Q1 2019 | $19,030,000 | – | 500,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |